| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |